We investigated the impact of IRF5 M1‐exos on lung cancer cell proliferation and tumor growth and, for the first time, identified that alterations in IRF5 expression result in significant upregulation of HLA‐E expression and promoter activity in lung cancer cell lines. The gene discussed is HLA-E; the disease is lung carcinoma.